Therefore, by inhibiting autophagy and P-gp efflux in drug-resistant cells, the tumor-targeting HA-MIL-125@DVMA nanoparticles presented a synergistic MDR reverse effect and can be utilized as a novel pathway for tumor resistance treatment. Here, PGP is linked to neoplasm.